206 related articles for article (PubMed ID: 11855991)
21. Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
Andreassen KV; Hjuler ST; Furness SG; Sexton PM; Christopoulos A; Nosjean O; Karsdal MA; Henriksen K
PLoS One; 2014; 9(3):e92042. PubMed ID: 24643196
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
[TBL] [Abstract][Full Text] [Related]
23. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes.
Nussenzveig DR; Thaw CN; Gershengorn MC
J Biol Chem; 1994 Nov; 269(45):28123-9. PubMed ID: 7961748
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
Arvinte T; Drake AF
J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
[TBL] [Abstract][Full Text] [Related]
26. Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.
Trier S; Linderoth L; Bjerregaard S; Strauss HM; Rahbek UL; Andresen TL
Eur J Pharm Biopharm; 2015 Oct; 96():329-37. PubMed ID: 26347924
[TBL] [Abstract][Full Text] [Related]
27. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
[TBL] [Abstract][Full Text] [Related]
28. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites.
Stroop SD; Kuestner RE; Serwold TF; Chen L; Moore EE
Biochemistry; 1995 Jan; 34(3):1050-7. PubMed ID: 7827020
[TBL] [Abstract][Full Text] [Related]
29. Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange.
Nabuchi Y; Asoh Y; Takayama M
J Am Soc Mass Spectrom; 2004 Nov; 15(11):1556-64. PubMed ID: 15519222
[TBL] [Abstract][Full Text] [Related]
30. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
31. Amylin is an agonist of the renal porcine calcitonin receptor.
Sexton PM; Houssami S; Brady CL; Myers DE; Findlay DM
Endocrinology; 1994 May; 134(5):2103-7. PubMed ID: 8156909
[TBL] [Abstract][Full Text] [Related]
32. Iodocalcitonin binds to human calcitonin receptors with higher affinity than calcitonin.
Cohen DP; Nussenzveig DR; Gershengorn MC
Endocrinology; 1996 Oct; 137(10):4507-10. PubMed ID: 8828514
[TBL] [Abstract][Full Text] [Related]
33. Analogues of human calcitonin. IV. Influence of leucine substitutions in positions 12, 16 and 19 on hypocalcaemic activity in the rat.
Maier R; Kamber B; Riniker B; Rittel W
Clin Endocrinol (Oxf); 1976; 5 Suppl():327S-332S. PubMed ID: 1052782
[TBL] [Abstract][Full Text] [Related]
34. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
Cheng W; Lim LY
Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
[TBL] [Abstract][Full Text] [Related]
35. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region.
Barbier JR; Neugebauer W; Morley P; Ross V; Soska M; Whitfield JF; Willick G
J Med Chem; 1997 Apr; 40(9):1373-80. PubMed ID: 9135034
[TBL] [Abstract][Full Text] [Related]
36. Conformational flexibility and biological activity of salmon calcitonin.
Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
[TBL] [Abstract][Full Text] [Related]
37. Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor.
Pham V; Wade JD; Purdue BW; Sexton PM
J Biol Chem; 2004 Feb; 279(8):6720-9. PubMed ID: 14623894
[TBL] [Abstract][Full Text] [Related]
38. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
Schwartz KE; Orlowski RC; Marcus R
Endocrinology; 1981 Mar; 108(3):831-5. PubMed ID: 6257497
[TBL] [Abstract][Full Text] [Related]
39. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagoshi Y; Eto T
Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
[TBL] [Abstract][Full Text] [Related]
40. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction.
Houssami S; Findlay DM; Brady CL; Myers DE; Martin TJ; Sexton PM
Endocrinology; 1994 Jul; 135(1):183-90. PubMed ID: 8013352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]